Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease

NCT03577652 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.

NCT NCT03577652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03577652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
Lead sponsor
Shenyang Northern Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 10, 2017
Completion date
January 10, 2018
Enrollment
108 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ticagrelor